L vs TCRX · P/E 14, rev $18.45B vs rev $2.0M
Loews Corp (L) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
L currently screens at market cap $22.36B and trailing P/E 13.8. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the L and TCRX stock pages for the full models.
Not investment advice.